Dr. Hönle AG provided earnings guidance for 2022. For the year, company announced that the Management Board expects sales of EUR 125 million to EUR 130 million and an operating result (EBIT) between EUR 9 million and EUR 11 million in the 2021/2022 financial year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.85 EUR | +1.79% | -0.25% | +13.43% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.43% | 128M | |
+14.92% | 85.88B | |
+19.25% | 70.83B | |
+18.36% | 36.65B | |
+24.23% | 34.25B | |
+9.19% | 27.96B | |
+5.22% | 27.05B | |
+7.20% | 26.89B | |
+21.55% | 26.82B | |
+19.44% | 25.32B |
- Stock Market
- Equities
- HNL Stock
- News Dr. Hönle AG
- Dr. Hönle AG Provides Earnings Guidance for 2022